Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$991000.0.

  • Biomerica's Cash from Operations fell 2528.45% to -$991000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$3.0 million, marking a year-over-year increase of 4046.18%. This contributed to the annual value of -$3.8 million for FY2025, which is 2835.29% up from last year.
  • According to the latest figures from Q4 2025, Biomerica's Cash from Operations is -$991000.0, which was down 2528.45% from -$268000.0 recorded in Q3 2025.
  • Over the past 5 years, Biomerica's Cash from Operations peaked at $2.4 million during Q1 2022, and registered a low of -$4.3 million during Q2 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$1.0 million (2021), whereas its average is -$939276.5.
  • Within the past 5 years, the most significant YoY rise in Biomerica's Cash from Operations was 27291.51% (2022), while the steepest drop was 217421.28% (2022).
  • Biomerica's Cash from Operations (Quarter) stood at $1.3 million in 2021, then crashed by 190.33% to -$1.2 million in 2022, then surged by 30.59% to -$842000.0 in 2023, then rose by 6.06% to -$791000.0 in 2024, then decreased by 25.28% to -$991000.0 in 2025.
  • Its Cash from Operations stands at -$991000.0 for Q4 2025, versus -$268000.0 for Q3 2025 and -$661000.0 for Q2 2025.